Kraig Biocraft Laboratories (KBLB) Stock Statistics & Valuation Metrics

Kraig Biocraft Laboratories has a market cap or net worth of $93.49M. The enterprise value is ―.

Kraig Biocraft Laboratories has 1,080,852,200 shares outstanding. The number of shares has decreased by -2.65% in one year.

Kraig Biocraft Laboratories’s return on equity (ROE) is 0.42 and return on invested capital (ROIC) is <0.01%.

The current PE Ratio of Kraig Biocraft Laboratories is ―. Kraig Biocraft Laboratories’s PEG ratio is -2.05.

In the last 12 months, Kraig Biocraft Laboratories had revenue of 0.00 and earned -3.40M in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was -1.85M and capital expenditures -8.02K, giving a free cash flow of -1.86M billion.

Kraig Biocraft Laboratories pays an annual dividend of ―, resulting in a dividend yield of ―

Kraig Biocraft Laboratories upcoming earnings date is ―, ―.

Kraig Biocraft Laboratories as a current ratio of <0.01, with Debt / Equity ratio of -19.78%

In the past 12 months, Kraig Biocraft Laboratories has paid 0.00 in taxes.

Kraig Biocraft Laboratories EV to EBITDA ratio is -34.24, with an EV/FCF ratio of -52.81.

Kraig Biocraft Laboratories has $1.57M in cash and marketable securities with $184.03K in debt, giving a net cash position of $1.38M billion.

Gross margin is 4.19%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Kraig Biocraft Laboratories is ―, which is 11.43% higher than the current price. The consensus rating is ―